This Study Aims to Determine the Long-term Persistence of Antibodies Against Hepatitis B and to Evaluate the Immunogenicity and Safety of Hepatitis B Vaccine in Adolescents Vaccinated in Infancy With Infanrix™ Hexa
Clinical trial NCT02052661 · COMPLETED
Trial details
- NCT number
- NCT02052661
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2014-02-18
- Primary completion
- 2014-09-23
- Enrollment
- 301
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.